Form EFFECT KAZIA THERAPEUTICS LTD
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 27, 2026 4:30 P.M. |
| Form: | F-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kazia files patent for paxalisib strategy in breast cancer
- Next Point LLC Releases The Physician’s Exit Plan for Medical Practice Owners Considering Their Next Chapter
- Citizens Commission on Human Rights International Announces Support for Stronger Deprescribing Safeguards and Reminds Parents of Federal Medication Protections
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
